The global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period. This growth is ...

Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.

Patient-adjusted nitrous oxide (N 2 O), commonly called laughing gas, did not reduce anxiety associated with transrectal prostate biopsy but significantly reduced pain as compared with standard ...